PROCEPT BioRobotics Corporation
PRCT
$39.69
-$1.55-3.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 79.18M | 69.16M | 68.24M | 58.37M | 53.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.18M | 69.16M | 68.24M | 58.37M | 53.35M |
| Cost of Revenue | 27.44M | 25.00M | 24.56M | 21.46M | 21.87M |
| Gross Profit | 51.75M | 44.16M | 43.67M | 36.91M | 31.48M |
| SG&A Expenses | 56.30M | 55.20M | 48.32M | 42.69M | 40.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.37M | 96.60M | 87.95M | 80.80M | 80.18M |
| Operating Income | -22.19M | -27.44M | -19.71M | -22.43M | -26.83M |
| Income Before Tax | -19.58M | -24.74M | -18.86M | -20.97M | -25.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.58M | -24.74M | -18.86M | -20.97M | -25.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.58M | -24.74M | -18.86M | -20.97M | -25.63M |
| EBIT | -22.19M | -27.44M | -19.71M | -22.43M | -26.83M |
| EBITDA | -20.60M | -25.96M | -18.26M | -21.10M | -25.56M |
| EPS Basic | -0.35 | -0.45 | -0.35 | -0.40 | -0.50 |
| Normalized Basic EPS | -0.22 | -0.28 | -0.22 | -0.25 | -0.31 |
| EPS Diluted | -0.35 | -0.45 | -0.35 | -0.40 | -0.50 |
| Normalized Diluted EPS | -0.22 | -0.28 | -0.22 | -0.25 | -0.31 |
| Average Basic Shares Outstanding | 55.45M | 54.92M | 53.84M | 52.01M | 51.62M |
| Average Diluted Shares Outstanding | 55.45M | 54.92M | 53.84M | 52.01M | 51.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |